Erratum: Evolution of expression of cardiac phenotypes over a 4-year period in the β-myosin heavy chain-Q403 transgenic rabbit model of human hypertrophic cardiomyopathy (Journal of Molecular and Cellular Cardiology (2004) 36 (663-673) DOI: 10.1016/j.yjmcc.2004.02.010);Evolution of expression of cardiac phenotypes over a 4-year period in the β-myosin heavy chain-Q403 transgenic rabbit model of human hypertrophic cardiomyopathy

Journal of Molecular and Cellular Cardiology

Volumn 36, Issue 5, 2004, Pages 663-673

  Nagueh, Sherif F ^a   Chen, Suetnee ^a   Patel, Rajnikant ^a   Tsybouleva, Natalia ^a   Lutucuta, Silvia ^a   Kopelen, Helen A ^a   Zoghbi, William A ^a   Quiñones, Miguel A ^a   Roberts, Robert ^a   Marian, A J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

ATPase; Cardiomyopathy; Echocardiography; Genetics; Hypertrophy; Tissue Doppler; Transgenic animal models

Indexed keywords

ADENOSINE TRIPHOSPHATASE; CALCIUM; GLUTAMINE; MYOSIN HEAVY CHAIN;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; ENZYME ACTIVITY; FEMALE; HEART CONTRACTION; HEART FUNCTION; HEART LEFT ATRIUM; HEART LEFT VENTRICLE; HEART MUSCLE FIBROSIS; HEART MUSCLE RELAXATION; HISTOLOGY; HYPERTROPHIC CARDIOMYOPATHY; MALE; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUBERTY; RABBIT; SIGNAL TRANSDUCTION; TRANSGENIC ANIMAL;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 2342521939     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2004.06.015     Document Type: Erratum

References (30)

1. Maron B.J., Olivotto I., Spirito P., Casey S.A., Bellone P., Gohman T.E., Graham K.J., Burton D.A., Cecchi F. Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population. Circulation. 102:2000;858-864
2. Maron B.J. Hypertrophic cardiomyopathy: a systematic review. JAMA. 287:2002;1308-1320
3. Marian A.J., Roberts R. The molecular genetic basis for hypertrophic cardiomyopathy. J Mol Cell Cardiol. 33:2001;655-670
4. Davies M.J., McKenna W.J. Hypertrophic cardiomyopathy - pathology and pathogenesis. Histopathology. 26:1995;493-500
5. Maron B.J., Shirani J., Poliac L.C., Mathenge R., Roberts W.C., Mueller F.O. Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles. JAMA. 276:1996;199-204
6. Spirito P., Bellone P., Harris K.M., Bernabo P., Bruzzi P., Maron B.J. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. N Engl J Med. 342:2000;1778-1785
7. Varnava A.M., Elliott P.M., Mahon N., Davies M.J., McKenna W.J. Relation between myocyte disarray and outcome in hypertrophic cardiomyopathy. Am J Cardiol. 88:2001;275-279
8. Shirani J., Pick R., Roberts W.C., Maron B.J. Morphology and significance of the left ventricular collagen network in young patients with hypertrophic cardiomyopathy and sudden cardiac death. J Am Coll Cardiol. 35:2000;36-44
9. Fatkin D., Graham R.M. Molecular mechanisms of inherited cardiomyopathies. Physiol Rev. 82:2002;945-980
10. Marian A.J., Roberts R. Molecular pathogenesis of cardiomyopathies. Sperelakis N., Kurachi Y., Terzic A., Cohen M. Heart Physiology and Pathophysiology. 2000;1045-1063 Academic Press, San Diego
11. Schwartz K., Lecarpentier Y., Martin J.L., Lompre A.M., Mercadier J.J., Swynghedauw B. Myosin isoenzymic distribution correlates with speed of myocardial contraction. J Mol Cell Cardiol. 13:1981;1071-1075
12. Alpert N.R., Brosseau C., Federico A., Krenz M., Robbins J., Warshaw D.M. Molecular mechanics of mouse cardiac myosin isoforms. Am J Physiol Heart Circ Physiol. 283:2002;H1446-H1454
13. Marian A.J., Wu Y., Lim D.S., McCluggage M., Youker K., Yu Q.T., Brugada R., DeMayo F., Quinones M., Roberts R. A transgenic rabbit model for human hypertrophic cardiomyopathy. J Clin Invest. 104:1999;1683-1692
14. Watkins H., Rosenzweig A., Hwang D.S., Levi T., McKenna W., Seidman C.E., Seidman J.G. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. N Engl J Med. 326:1992;1108-1114
15. Marian A.J., Wu Y., Lim D.S., McCluggage M., Youker K., Yu Q.T., Brugada R., DeMayo F., Quinones M., Roberts R. A transgenic rabbit model for human hypertrophic cardiomyopathy. J Clin Invest. 104:1999;1683-1692
16. Nagueh S.F., Kopelen H.A., Lim D.S., Zoghbi W.A., Quinones M.A., Roberts R., Marian A.J. Tissue Doppler imaging consistently detects myocardial contraction and relaxation abnormalities, irrespective of cardiac hypertrophy, in a transgenic rabbit model of human hypertrophic cardiomyopathy. Circulation. 102:2000;1346-1350
17. Suckow M.A., Douglas F.A. The Laboratory Rabbit. 1997;CRC Press, Boca Raton, New York
18. Maron B.J., Spirito P., Wesley Y., Arce J. Development and progression of left ventricular hypertrophy in children with hypertrophic cardiomyopathy. N Engl J Med. 315:1986;610-614
19. Patel R., Nagueh S.F., Tsybouleva N., Abdellatif M., Lutucuta S., Kopelen H.A., Quinones M.A., Zoghbi W.A., Entman M.L., Roberts R., Marian A.J. Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy. Circulation. 104:2001;317-324
20. Solaro R.J., Pang D.C., Briggs F.N. The purification of cardiac myofibrils with Triton X-100. Biochim Biophys Acta. 245:1971;259-262
21. Oh H., Taffet G.E., Youker K.A., Entman M.L., Overbeek P.A., Michael L.H., Schneider M.D. Telomerase reverse transcriptase promotes cardiac muscle cell proliferation, hypertrophy, and survival. Proc Natl Acad Sci U S A. 98:2001;10308-10313
22. Prunier F., Gaertner R., Louedec L., Michel J.B., Mercadier J.J., Escoubet B. Doppler echocardiographic estimation of left ventricular end-diastolic pressure after MI in rats. Am J Physiol Heart Circ Physiol. 283:2002;H346-H352
23. Bueno O.F., Molkentin J.D. Involvement of extracellular signal-regulated kinases 1/2 in cardiac hypertrophy and cell death. Circ Res. 91:2002;776-781
24. Crilley J.G., Boehm E.A., Blair E., Rajagopalan B., Blamire A.M., Styles P., McKenna W.J., Ostman-Smith I., Clarke K., Watkins H. Hypertrophic cardiomyopathy due to sarcomeric gene mutations is characterized by impaired energy metabolism irrespective of the degree of hypertrophy. J Am Coll Cardiol. 41:2003;1776-1782
25. Nagueh S.F., Bachinski L., Meyer D., Hill R., Zoghbi W.A., Tam J.W., Quinones M.A., Roberts R., Marian A.J. Tissue Doppler imaging consistently detects myocardial abnormalities in patients with familial hypertrophic cardiomyopathy and provides a novel means for an early diagnosis prior to an independent of hypertrophy. Circulation. 104:2001;128-130
26. Nagueh S.F., McFalls J., Meyer D., Hill R., Zoghbi W.A., Tam J.W., Quinones M.A., Roberts R., Marian A.J. Tissue Doppler imaging predicts the development of hypertrophic cardiomyopathy in subjects with subclinical disease. Circulation. 108:2003;395-398
27. Yamazaki T., Komuro I., Yazaki Y. Signalling pathways for cardiac hypertrophy. Cell Signal. 10:1998;693-698
28. Nagueh S.F., Lakkis N.M., Middleton K.J., Spencer W.H. III, Zoghbi W.A., Quinones M.A. Doppler estimation of left ventricular filling pressures in patients with hypertrophic cardiomyopathy. Circulation. 99:1999;254-261
29. Nagueh S.F., Middleton K.J., Kopelen H.A., Zoghbi W.A., Quinones M.A. Doppler tissue imaging: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol. 30:1997;1527-1533
30. Geisterfer-Lowrance A.A., Christe M., Conner D.A., Ingwall J.S., Schoen F.J., Seidman C.E., Seidman J.G. A mouse model of familial hypertrophic cardiomyopathy. Science. 272:1996;731-734